Trastuzumab rezetecan Antibody
Trastuzumab rezetecan (SHR-A1811) is a HER2-targeting antibody-drug conjugate (ADC) for research, incorporating a cleavable linker and the topoisomerase I inhibitor Rezetecan. It is applied in studies of HER2-positive breast cancer, demonstrating activity in both in vitro cell assays and in vivo tumor models.
Product Specifications
Target
EGFR, Antibody-Drug Conjugates (ADCs)
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog